107 related articles for article (PubMed ID: 3345825)
21. Effects of human marrow stromal cells on proliferation by human granulocytic (GM-CFC), erythroid (BFU-E) and mixed (Mix-CFC) colony-forming cells.
Gordon MY; Kearney L; Hibbin JA
Br J Haematol; 1983 Feb; 53(2):317-25. PubMed ID: 6600399
[TBL] [Abstract][Full Text] [Related]
22. Colony inhibiting factor in mature granulocytes from normal individuals and patients with chronic myeloid leukemia.
Bøyum A; Løvhaug D; Kolstø AB; Helgestad J; Melby T
Eur J Haematol; 1987 Apr; 38(4):318-26. PubMed ID: 3475214
[TBL] [Abstract][Full Text] [Related]
23. Human placental conditioned medium (from different phase of pregnancy) as a source of colony-stimulating activity for cultures of human and mouse. granulocyte-macrophage colony-forming cells in semisolid agar.
Cinátl J; Lemez P; Hermanová E; Chudomel V; Neuwirtová R; Neuwirt J; Zivný J; Necas E
Folia Biol (Praha); 1981; 27(3):186-93. PubMed ID: 6973492
[TBL] [Abstract][Full Text] [Related]
24. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
25. A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells.
Kajigaya S; Suda T; Suda J; Saito M; Miura Y; Iizuka M; Kobayashi S; Minato N; Sudo T
J Exp Med; 1986 Oct; 164(4):1102-13. PubMed ID: 3489806
[TBL] [Abstract][Full Text] [Related]
26. Ontogeny of the granulocyte/macrophage progenitor cell (GM-CFC) pools in the beagle.
Nothdurft W; Braasch E; Calvo W; Prümmer O; Carbonell F; Grilli G; Fliedner TM
J Embryol Exp Morphol; 1984 Apr; 80():87-103. PubMed ID: 6747533
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.
Naldini A; Fleischmann WR; Ballas ZK; Klimpel KD; Klimpel GR
J Immunol; 1987 Sep; 139(6):1880-4. PubMed ID: 2442258
[TBL] [Abstract][Full Text] [Related]
28. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen.
Cen D; Levin J
Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543
[TBL] [Abstract][Full Text] [Related]
29. Hemopoietic progenitor cells in the blood as indicators of the functional status of the bone marrow after total-body and partial-body irradiation: experiences from studies in dogs.
Nothdurft W; Kreja L
Stem Cells; 1998; 16 Suppl 1():97-111. PubMed ID: 11012152
[TBL] [Abstract][Full Text] [Related]
30. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein.
Gran C; Bøyum A; Johansen RF; Løvhaug D; Seeberg EC
Blood; 1998 Jun; 91(11):4127-35. PubMed ID: 9596658
[TBL] [Abstract][Full Text] [Related]
32. A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro.
Schneider GB; Relfson M
Bone; 1988; 9(5):303-8. PubMed ID: 3203017
[TBL] [Abstract][Full Text] [Related]
33. Thymic inhibition of myelopoietic proliferation.
Gruber DF; Ledney GD
Adv Exp Med Biol; 1984; 172():227-40. PubMed ID: 6731146
[TBL] [Abstract][Full Text] [Related]
34. Characterization of possible receptor of colony-promoting activity (CPA) by comparison with that of colony-stimulating factor (CSF).
Izumi H; Oshima H; Mori KJ; Frindel E
Exp Hematol; 1984 May; 12(4):231-6. PubMed ID: 6325225
[TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human granulocyte colony-stimulating factor treatment improves macrophage suppression of granulocyte and macrophage growth after burn and burn wound infection.
Gamelli RL; He LK; Liu H
J Trauma; 1995 Dec; 39(6):1141-6; discussion 1146-7. PubMed ID: 7500409
[TBL] [Abstract][Full Text] [Related]
37. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
[TBL] [Abstract][Full Text] [Related]
39. Effects of aflatoxin B1 and T-2 toxin on the granulocyte-macrophage progenitor cells in mouse bone marrow cultures.
Dugyala RR; Kim YW; Sharma RP
Immunopharmacology; 1994; 27(1):57-65. PubMed ID: 8206754
[TBL] [Abstract][Full Text] [Related]
40. A new experimental protocol as an alternative to the colony-forming unit-granulocyte/macrophage (CFU-GM) clonogenic assay to assess the haematotoxic potential of new drugs.
Dal Negro G; Vandin L; Bonato M; Repeto P; Sciuscio D
Toxicol In Vitro; 2006 Aug; 20(5):750-6. PubMed ID: 16321498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
